Publications by authors named "Georgina Long"

Claim this Profile
A
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
Georgina V Long, Charlie Garnett-Benson, Sonia Dolfi, Paolo A Ascierto, Jun Guo

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations.
Derek Effiom, Tyler Aprati, Anastasios Karneris, Aleigha Lawless, Tatyana Sharova, Georgina Long

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity.
Minke W Lucas, Elizabeth M Burton, Petros Dimitriadis, Alexander C Huang, Georgina V Long

Immunity· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular Function After Immune-Checkpoint Inhibitors Treatment.
Andrea Boutros, Amanda Idan, Sue Sleiman, Feyrous Bacha, Ting Zhang, Georgina V Long

Clin Endocrinol (Oxf)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.
Georgina V Long, Nitya Nair, Daniel Marbach, Richard A Scolyer, Sabine Wilson

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.
Jessica S W Borgers, Douglas B Johnson, Elisabeth Livingstone, Dirk Schadendorf, Elizabeth I Buchbinder, Georgina V Long

EClinicalMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Amanpreet Kaur, Marie R Webster, Katie Marchbank, Reeti Behera, Abibatou Ndoye, Georgina V Long

Nature· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans.
Linda Wu, John M Wentworth, Christopher Liddle, Nicole Fewings, Matteo Carlino, Georgina V Long

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma.
Fei Yang, Su Yin Lim, Ines Pires da Silva, Lijia Yu, Jordan W Conway, Georgina V Long

Cancer Cell Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International real-world study of combination immunotherapy sequences in metastatic melanoma.
Mora Guardamagna, Sarah E Lochrin, James William Smithy, Michael Postow, Caroline Gaudy-Marqueste, Georgina V Long

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis.
Terence Wong, Sydney Ch'ng, Peter Ferguson, Linda Martin, Alexander M Menzies, Georgina V Long

Crit Rev Oncol Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Advanced Melanoma.
Antoni Ribas, Mohammed M Milhem, Christopher J Hoimes, Asim Amin, Christopher D Lao, Georgina V Long

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.
Christian Menzer, Susanne Dugas-Breit, Martin Dugas, Christian U Blank, Emma J Groen, Georgina V Long

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma.
Andrea Boutros, Amelia M Taylor, Isabel Li, Nurudeen A Adegoke, Terence Wong, Georgina V Long

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structured curriculum vitae scoring: a possible means to improve female representation in specialty selection?
Brittany Suann, Christina Gao, Thomas Muecke, Haelynn Gim, Joshua Kovoor, Georgina V Long

Intern Med J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.
Elan Novis, Mervi Rautalin, Rodabe N Amaria, Paolo A Ascierto, Christian U Blank, Georgina V Long

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol of a randomised phase II trial of concurrent stereotactic body radiotherapy with immunotherapy versus immunotherapy alone in patients with 1-5 extracranial melanoma oligometastases (AXIOM).
Angela M Hong, Tim Wang, Matteo S Carlino, Serigne N Lo, Alexander M Menzies, Georgina V Long

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors.
Ismael A Vergara, Nigel G Maher, Alison J Potter, Elizabeth C Paver, Jordan W Conway, Georgina V Long

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.
Evan J Lipson, Sonia Dolfi, Hao Tang, Hussein A Tawbi, Francisco Medina-Soto, Georgina V Long

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.
Meredith M Regan, Paolo A Ascierto, Evan J Lipson, Jennell Palaia, Andriy Moshyk, Georgina V Long

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.
Judith M Versluis, Huma Shehwana, Robert Elens, Alexander M Menzies, Irene L M Reijers, Georgina V Long

Commun Med (Lond)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.
Mario Mandalà, Teresa Amaral, Piotr Rutkowski, Maria Chiara Sergi, Marie-Lena Rasch, Georgina V Long

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update.
Evan J Lipson, F Stephen Hodi, Hussein Tawbi, Dirk Schadendorf, Paolo A Ascierto, Georgina V Long

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915.
Georgina V Long, Hao Tang, Keyur Desai, Sheen Wang, Michele Del Vecchio

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity.
Wei Yen Chan, Ashleigh Stewart, Russell J Diefenbach, Elin S Gray, Jenny H Lee, Georgina V Long

Biomolecules· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis